PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 93 filers reported holding PLIANT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $36,949,470 | -28.7% | 3,437,160 | -1.2% | 0.00% | 0.0% |
Q1 2024 | $51,827,489 | -6.7% | 3,478,355 | +13.5% | 0.00% | 0.0% |
Q4 2023 | $55,522,888 | +8.7% | 3,065,869 | +4.1% | 0.00% | 0.0% |
Q3 2023 | $51,071,710 | +1.5% | 2,945,312 | +6.1% | 0.00% | 0.0% |
Q2 2023 | $50,316,667 | -20.3% | 2,776,858 | +17.0% | 0.00% | -50.0% |
Q1 2023 | $63,114,405 | +67.5% | 2,372,722 | +21.7% | 0.00% | +100.0% |
Q4 2022 | $37,675,021 | +12.8% | 1,949,044 | +21.9% | 0.00% | 0.0% |
Q3 2022 | $33,410,000 | +296.2% | 1,599,324 | +51.9% | 0.00% | – |
Q2 2022 | $8,433,000 | -2.4% | 1,052,686 | -14.6% | 0.00% | – |
Q1 2022 | $8,642,000 | -47.5% | 1,232,699 | +1.2% | 0.00% | – |
Q4 2021 | $16,449,000 | -31.3% | 1,218,410 | -14.1% | 0.00% | -100.0% |
Q3 2021 | $23,946,000 | -35.3% | 1,418,599 | +11.6% | 0.00% | 0.0% |
Q2 2021 | $37,030,000 | -14.6% | 1,271,656 | +15.3% | 0.00% | 0.0% |
Q1 2021 | $43,369,000 | +276.6% | 1,102,685 | +117.5% | 0.00% | – |
Q4 2020 | $11,517,000 | +15.3% | 506,959 | +15.0% | 0.00% | – |
Q3 2020 | $9,988,000 | +1130.0% | 440,993 | +1664.0% | 0.00% | – |
Q2 2020 | $812,000 | – | 25,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mass General Brigham, Inc | 288,690 | $3,103,418 | 15.11% |
TRV GP IV, LLC | 2,132,867 | $22,928,320 | 11.34% |
Blue Owl Capital Holdings LP | 3,004,199 | $32,295,139 | 8.98% |
GREAT POINT PARTNERS LLC | 2,636,864 | $28,346,288 | 5.43% |
First Light Asset Management, LLC | 3,401,213 | $36,563,040 | 3.20% |
Redmile Group, LLC | 3,209,591 | $34,503,103 | 2.09% |
Deep Track Capital, LP | 5,972,257 | $64,201,763 | 1.92% |
Fernwood Investment Management, LLC | 496,286 | $5,335,075 | 1.66% |
Checkpoint Capital L.P. | 232,200 | $2,496,150 | 1.50% |
Exome Asset Management LLC | 124,000 | $1,333,000 | 1.16% |